Millennia Portfolio Company, Collegium Pharmaceutical Inc., a specialty pharmaceutical company developing abuse-deterrent products, announced the closing of its initial public offering of 6,670,000 shares of its common stock at a price to the public of $12.00 per share. (Nasdaq:COLL)